Jan Jenkins

719 total citations
23 papers, 546 citations indexed

About

Jan Jenkins is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Jan Jenkins has authored 23 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 6 papers in Oncology. Recurrent topics in Jan Jenkins's work include Sarcoma Diagnosis and Treatment (6 papers), Esophageal and GI Pathology (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Jan Jenkins is often cited by papers focused on Sarcoma Diagnosis and Treatment (6 papers), Esophageal and GI Pathology (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Jan Jenkins collaborates with scholars based in United States. Jan Jenkins's co-authors include M. A. Burgess, Carl Plager, Nicholas Papadopolous, Shreyaskumar Patel, Robert S. Benjamin, William Plunkett, Varsha Gandhi, Saroj Vadhan‐Raj, J. U. Gutterman and Raj Singh and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Frontiers in Immunology.

In The Last Decade

Jan Jenkins

20 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Jenkins United States 9 370 331 109 101 85 23 546
U. Matulonis United States 9 252 0.7× 342 1.0× 80 0.7× 125 1.2× 57 0.7× 33 596
Vaia Florou United States 11 512 1.4× 655 2.0× 218 2.0× 82 0.8× 106 1.2× 56 822
Pier Paolo Fattori Italy 10 253 0.7× 275 0.8× 25 0.2× 97 1.0× 74 0.9× 24 642
Myung Hee Chang South Korea 17 246 0.7× 385 1.2× 18 0.2× 118 1.2× 131 1.5× 50 718
Samer Salah Jordan 14 491 1.3× 323 1.0× 69 0.6× 61 0.6× 189 2.2× 59 726
Henry A. Briele United States 13 258 0.7× 412 1.2× 57 0.5× 121 1.2× 115 1.4× 18 580
Berna Bozkurt Duman Türkiye 14 83 0.2× 195 0.6× 39 0.4× 96 1.0× 70 0.8× 57 450
Wai Chin Foo United States 15 287 0.8× 389 1.2× 43 0.4× 152 1.5× 297 3.5× 51 820
Viktor Gruenwald Germany 14 368 1.0× 236 0.7× 19 0.2× 183 1.8× 65 0.8× 53 586
Marion Marty France 12 136 0.4× 209 0.6× 20 0.2× 217 2.1× 137 1.6× 40 561

Countries citing papers authored by Jan Jenkins

Since Specialization
Citations

This map shows the geographic impact of Jan Jenkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Jenkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Jenkins more than expected).

Fields of papers citing papers by Jan Jenkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Jenkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Jenkins. The network helps show where Jan Jenkins may publish in the future.

Co-authorship network of co-authors of Jan Jenkins

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Jenkins. A scholar is included among the top collaborators of Jan Jenkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Jenkins. Jan Jenkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farina, Juan, et al.. (2025). TAV-in-TAV Explant Through Surgical Resection of Prosthetic Valve Leaflets Under Direct Vision: SURPLUS+. Methodist DeBakey Cardiovascular Journal. 21(1). 20–24.
2.
3.
Jenkins, Jan, et al.. (2024). Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation. Frontiers in Immunology. 15. 1341675–1341675. 7 indexed citations
4.
Farina, Juan, Jan Jenkins, Eric H. Yang, et al.. (2024). Surgical Removal of a Migrated WATCHMAN Device. Methodist DeBakey Cardiovascular Journal. 20(1). 80–86. 1 indexed citations
5.
Brady, Justin T., et al.. (2024). Lymphovascular Invasion is an Independent Negative Prognostic Factor in Esophageal Adenocarcinoma. Annals of Surgical Oncology. 31(10). 6680–6690.
6.
Jenkins, Jan, Juan Farina, Ashraf Omar, et al.. (2024). Lung Transplantation in the United States for COVID-19 Related Lung Disease During the Pandemic. Lung. 202(5). 723–737. 2 indexed citations
7.
Jaroszewski, Dawn E., et al.. (2024). Phoenix Comprehensive Assessment of Pectus Excavatum Symptoms (PCAPES). Journal of Thoracic Disease. 16(12). 8565–8581. 1 indexed citations
8.
Singh, Raj, Jan Jenkins, Joanne Davis, et al.. (2023). Improved local control following dose-escalated stereotactic ablative radiation therapy (SABR) for metastatic sarcomas: An international multi-institutional experience. Radiotherapy and Oncology. 190. 110020–110020. 2 indexed citations
9.
Singh, Raj, Jan Jenkins, Joanne Davis, et al.. (2022). A multi-institutional analysis of outcomes following stereotactic body radiation therapy for management of metastases from squamous cell carcinomas of the head and neck.. PubMed. 8(1). 11–19. 7 indexed citations
10.
Jenkins, Jan, Schelomo Marmor, Jane Yuet Ching Hui, et al.. (2021). The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer. Breast Cancer Research and Treatment. 191(2). 401–407. 8 indexed citations
11.
Singh, Raj, et al.. (2020). Stereotactic body radiation therapy (SBRT) for metastatic renal cell carcinoma: A multi-institutional experience.. PubMed. 7(1). 29–37. 10 indexed citations
12.
Singh, Raj, et al.. (2019). Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma. American Journal of Clinical Oncology. 42(7). 602–606. 9 indexed citations
13.
Singh, Raj, et al.. (2019). Stereotactic radiosurgery and fractionated stereotactic radiosurgery for vestibular schwannomas: A comparison of clinical outcomes from the RSSearch patient registry.. PubMed. 6(1). 19–26. 3 indexed citations
14.
15.
Patel, Shreyaskumar, Jennifer Beach, Nikolaos G. Papadopoulos, et al.. (2003). Results of a 2‐arm Phase II study of 9‐nitrocamptothecin in patients with advanced soft‐tissue sarcomas. Cancer. 97(11). 2848–2852. 25 indexed citations
16.
Patel, Shreyaskumar, Varsha Gandhi, Jan Jenkins, et al.. (2001). Phase II Clinical Investigation of Gemcitabine in Advanced Soft Tissue Sarcomas and Window Evaluation of Dose Rate on Gemcitabine Triphosphate Accumulation. Journal of Clinical Oncology. 19(15). 3483–3489. 200 indexed citations
17.
Jenkins, Jan, et al.. (2001). Pilot study of vitaxin?an angiogenesis inhibitor?in patients with advanced leiomyosarcomas. Cancer. 92(5). 1347–1348. 74 indexed citations
18.
Patel, Shreyaskumar, Saroj Vadhan‐Raj, M. A. Burgess, et al.. (1998). Results of Two Consecutive Trials of Dose-Intensive Chemotherapy With Doxorubicin and Ifosfamide in Patients With Sarcomas. American Journal of Clinical Oncology. 21(3). 317–321. 151 indexed citations
19.
Patel, Shreyaskumar, M. A. Burgess, Nicholas Papadopolous, et al.. (1998). Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomas. Investigational New Drugs. 16(1). 87–92. 10 indexed citations
20.
Patel, Shreyaskumar, M. A. Burgess, Nicholas E. Papadopoulos, et al.. (1997). Phase II Study of Paclitaxel in Patients With Soft Tissue Sarcomas. Sarcoma. 1(2). 95–97. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U. Matulonis Breakdown of academic impact, for papers by Vaia Florou Breakdown of academic impact, for papers by Pier Paolo Fattori Breakdown of academic impact, for papers by Myung Hee Chang Breakdown of academic impact, for papers by Samer Salah Breakdown of academic impact, for papers by Henry A. Briele Breakdown of academic impact, for papers by Berna Bozkurt Duman Breakdown of academic impact, for papers by Wai Chin Foo Breakdown of academic impact, for papers by Viktor Gruenwald Breakdown of academic impact, for papers by Marion Marty
Rankless by CCL
2026